Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Circumpapillary OCT-Focused Hybrid Learning for Glaucoma Grading Using Tailored Prototypical Neural Networks

  • García-Pardo, José Gabriel
  • Verdú-Monedero, Rafael
  • Morales-Sanchez, Juan
  • del Amor, Rocío
  • Colomer, Adrián|||0000-0002-7616-6029
  • Naranjo Ornedo, Valeriana|||0000-0002-0181-3412
[EN] Glaucoma is one of the leading causes of blindness worldwide and Optical Coherence Tomography (OCT) is the quintessential imaging technique for its detection. Unlike most of the state-of-the-art studies focused on glaucoma detection, in this paper, we propose, for the first time, a novel framework for glaucoma grading using raw circumpapillary B-scans. In particular, we set out a new OCT-based hybrid network which combines hand-driven and deep learning algorithms. An OCT-specific descriptor is proposed to extract hand-crafted features related to the retinal nerve fibre layer (RNFL). In parallel, an innovative CNN is developed using skip-connections to include tailored residual and attention modules to refine the automatic features of the latent space. The proposed architecture is used as a backbone to conduct a novel few-shot learning based on static and dynamic prototypical networks. The k-shot paradigm is redefined giving rise to a supervised end-to-end system which provides substantial improvements discriminating between healthy, early and advanced glaucoma samples. The training and evaluation processes of the dynamic prototypical network are addressed from two fused databases acquired via Heidelberg Spectralis system. Validation and testing results reach a categorical accuracy of 0.9459 and 0.8788 for glaucoma grading, respectively. Besides, the high performance reported by the proposed model for glaucoma detection deserves a special mention. The findings from the class activation maps are directly in line with the clinicians' opinion since the heatmaps pointed out the RNFL as the most relevant structure for glaucoma diagnosis., This work has been partially funded by the following projects: [H2020-ICT-2016-2017, 732613] , DPI2016-77869-C2-1-R, PROM-ETEO/2019/109, AES2017-PI17/00771, AES2017-PI17/00821 and 20901/PI/18. The work of Gabriel Garcia has been supported by the Spanish State Research Agency PTA2017-14610-I
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Automatic Segmentation of the Retinal Nerve Fiber Layer by Means of Mathematical Morphology and Deformable Models in 2D Optical Coherence Tomography Imaging

  • Berenguer-Vidal, Rafael
  • Verdú-Monedero, Rafael
  • Morales-Sánchez, Juan
  • Sellés-Navarro, Inmaculada
  • García-Pardo, José Gabriel
  • del Amor, Rocío
  • Naranjo Ornedo, Valeriana|||0000-0002-0181-3412
[EN] Glaucoma is a neurodegenerative disease process that leads to progressive damage of the optic nerve to produce visual impairment and blindness. Spectral-domain OCT technology enables peripapillary circular scans of the retina and the measurement of the thickness of the retinal nerve fiber layer (RNFL) for the assessment of the disease status or progression in glaucoma patients. This paper describes a new approach to segment and measure the retinal nerve fiber layer in peripapillary OCT images. The proposed method consists of two stages. In the first one, morphological operators robustly detect the coarse location of the layer boundaries, despite the speckle noise and diverse artifacts in the OCT image. In the second stage, deformable models are initialized with the results of the previous stage to perform a fine segmentation of the boundaries, providing an accurate measurement of the entire RNFL. The results of the RNFL segmentation were qualitatively assessed by ophthalmologists, and the measurements of the thickness of the RNFL were quantitatively compared with those provided by the OCT inbuilt software as well as the state-of-the-art methods., This work was partially funded by Spanish National projects AES2017-PI17/00771 and AES2017-PI17/00821 (Instituto de Salud Carlos III), PID2019-105142RB-C21 (AI4SKIN) (Spanish Ministry of Economy and Competitiveness), PTA2017-14610-I (State Research Spanish Agency), regional project 20901/PI/18 (Fundacion Seneca) and Polytechnic University of Valencia (PAID-01-20).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis

  • Isidro-Hernández, Marta
  • Mayado, Andrea
  • Casado-García, Ana
  • Martínez-Cano, Jorge
  • Palmi, Chiara
  • Fazio, Grazia
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera Salas, Jordi|||0000-0003-4796-6470
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Raboso-Gallego, Javier
  • Blanco, Óscar
  • Alonso-López, Diego
  • De Las Rivas, Javier
  • Jiménez, Rafael|||0000-0003-4103-8219
  • García Criado, Francisco Javier
  • García Cenador, María Begoña
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Cazzaniga, Giovanni|||0000-0003-2955-4528
  • Cobaleda, Cesar|||0000-0003-3807-9204
  • Vicente-Dueñas, Carolina
  • Sánchez García, Isidro
PAX5 is one of the most frequently mutated genes in B-cell acute lymphoblastic leukemia (B-ALL), and children with inherited preleukemic PAX5 mutations are at a higher risk of developing the disease. Abnormal profiles of inflammatory markers have been detected in neonatal blood spot samples of children who later developed B-ALL. However, how inflammatory signals contribute to B-ALL development is unclear. Here, we demonstrate that Pax5 heterozygosis, in the presence of infections, results in the enhanced production of the inflammatory cytokine interleukin-6 (IL-6), which appears to act in an autocrine fashion to promote leukemia growth. Furthermore, in vivo genetic downregulation of IL-6 in these Pax5 heterozygous mice retards B-cell leukemogenesis, and in vivo pharmacologic inhibition of IL-6 with a neutralizing antibody in Pax5 mutant mice with B-ALL clears leukemic cells. Additionally, this novel IL-6 signaling paradigm identified in mice was also substantiated in humans. Altogether, our studies establish aberrant IL6 expression caused by Pax5 loss as a hallmark of Pax5-dependent B-ALL and the IL6 as a therapeutic vulnerability for B-ALL characterized by PAX5 loss.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Endogenous Syngap1 Alpha Splice Forms Promote Cognitive Function and Seizure Protection

  • Kilinc, Murat
  • Arora, Vineet
  • Creson, Thomas K.
  • Rojas, Camilo
  • Le, Aliza A.
  • Lauterborn, Julie
  • Wilkinson, Brent
  • Hartel, Nicolas
  • Graham, Nicholas
  • Reich, Adrian
  • Gou Alsina, Gemma|||0000-0001-7438-2417
  • Araki, Yoichi
  • Bayés, Àlex|||0000-0002-5265-6306
  • Coba, Marcelo P.
  • Lynch, Gary
  • Miller, Courtney A.
  • Rumbaugh, Gumbaugh
Loss-of-function variants in SYNGAP1 cause a developmental encephalopathy defined by cognitive impairment, autistic features, and epilepsy. SYNGAP1 splicing leads to expression of distinct functional protein isoforms. Splicing imparts multiple cellular functions of SynGAP proteins through coding of distinct C-terminal motifs. However, it remains unknown how these different splice sequences function in vivo to regulate neuronal function and behavior. Reduced expression of SynGAP-α1/2 C-terminal splice variants in mice caused severe phenotypes, including reduced survival, impaired learning, and reduced seizure latency. In contrast, upregulation of α1/2 expression improved learning and increased seizure latency. Mice expressing α1-specific mutations, which disrupted SynGAP cellular functions without altering protein expression, promoted seizure, disrupted synapse plasticity, and impaired learning. These findings demonstrate that endogenous SynGAP isoforms with α1/2 spliced sequences promote cognitive function and impart seizure protection. Regulation of SynGAP-α expression or function may be a viable therapeutic strategy to broadly improve cognitive function and mitigate seizure.